{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:20:06Z","timestamp":1792801206022,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["(2011)872"],"award-info":[{"award-number":["(2011)872"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660114"],"award-info":[{"award-number":["81660114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860122"],"award-info":[{"award-number":["81860122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi Province Outstanding Youth Talent Funding Program","award":["20192BCBL23021"],"award-info":[{"award-number":["20192BCBL23021"]}]},{"name":"Science and Technology Research Project of Jiangxi Provincial Department of Education","award":["60125"],"award-info":[{"award-number":["60125"]}],"id":[{"id":"https:\/\/ror.org\/05r16bb17","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intra-abdominal hypertension (IAH) in acute pancreatitis (AP) is associated with deterioration in organ function. This trial aimed to assess the efficacy of neostigmine for IAH in patients with AP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center, randomized trial, consenting patients with IAH within 2\u00a0weeks of AP onset received conventional treatment for 24\u00a0h. Patients with sustained intra-abdominal pressure (IAP)\u2009\u2265\u200912\u00a0mmHg were randomized to receive intramuscular neostigmine (1\u00a0mg every 12\u00a0h increased to every 8\u00a0h or every 6\u00a0h, depending on response) or continue conventional treatment for 7\u00a0days. The primary outcome was the percent change of IAP at 24\u00a0h after randomization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 80 patients were recruited to neostigmine (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940) or conventional treatment (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940). There was no significant difference in baseline parameters. The rate of decrease in IAP was significantly faster in the neostigmine group compared to the conventional group by 24\u00a0h (median with 25th\u201375th percentile: \u221218.7% [\u2212\u200928.4 to \u2212\u20094.7%] vs. \u2212\u20095.4% [\u2212\u200918.0% to 0],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.017). This effect was more pronounced in patients with baseline IAP\u2009\u2265\u200915\u00a0mmHg (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.018). Per-protocol analysis confirmed these results (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03). Stool volume was consistently higher in the neostigmine group during the 7-day observational period (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Other secondary outcomes were not significantly different between neostigmine and conventional treatment groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Neostigmine reduced IAP and promoted defecation in patients with AP and IAH. These results warrant a larger, placebo-controlled, double-blind phase III trial.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      Clinical Trial No:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02543658\">NCT02543658<\/jats:ext-link>\n                      (registered August \/27, 2015).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-022-03922-4","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T05:04:03Z","timestamp":1646283843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Randomized controlled trial: neostigmine for intra-abdominal hypertension in acute pancreatitis"],"prefix":"10.1186","volume":"26","author":[{"given":"Wenhua","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajing","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4373-551X","authenticated-orcid":false,"given":"Nonghua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"3922_CR1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jama.2020.20317","volume":"325","author":"MA Mederos","year":"2021","unstructured":"Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021;325:382\u201390.","journal-title":"JAMA"},{"key":"3922_CR2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/SLA.0000000000000264","volume":"259","author":"Q Guo","year":"2014","unstructured":"Guo Q, Li A, Xia Q, et al. The role of organ failure and infection in necrotizing pancreatitis: a prospective study. Ann Surg. 2014;259:1201\u20137.","journal-title":"Ann Surg"},{"key":"3922_CR3","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/gutjnl-2017-314657","volume":"68","author":"NJ Schepers","year":"2019","unstructured":"Schepers NJ, Bakker OJ, Besselink MG, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis. Gut. 2019;68:1044\u201351.","journal-title":"Gut"},{"key":"3922_CR4","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1053\/j.gastro.2018.12.041","volume":"156","author":"PK Garg","year":"2019","unstructured":"Garg PK, Singh VP. Organ failure due to systemic injury in acute pancreatitis. Gastroenterology. 2019;156:2008\u201323.","journal-title":"Gastroenterology"},{"key":"3922_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1136\/gutjnl-2019-318241","volume":"69","author":"N Shi","year":"2020","unstructured":"Shi N, Liu T, de la Iglesia-Garcia D, et al. Duration of organ failure impacts mortality in acute pancreatitis. Gut. 2020;69:604\u20135.","journal-title":"Gut"},{"key":"3922_CR6","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s00134-013-2906-z","volume":"39","author":"AW Kirkpatrick","year":"2013","unstructured":"Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39:1190\u2013206.","journal-title":"Intensive Care Med"},{"key":"3922_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.pan.2014.06.002","volume":"14","author":"G Trikudanathan","year":"2014","unstructured":"Trikudanathan G, Vege SS. Current concepts of the role of abdominal compartment syndrome in acute pancreatitis: an opportunity or merely an epiphenomenon. Pancreatology. 2014;14:238\u201343.","journal-title":"Pancreatology"},{"key":"3922_CR8","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.surg.2013.12.028","volume":"155","author":"EL Aitken","year":"2014","unstructured":"Aitken EL, Gough V, Jones A, et al. Observational study of intra-abdominal pressure monitoring in acute pancreatitis. Surgery. 2014;155:910\u20138.","journal-title":"Surgery"},{"key":"3922_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/MPA.0000000000000108","volume":"43","author":"S van Brunschot","year":"2014","unstructured":"van Brunschot S, Schut AJ, Bouwense SA, et al. Abdominal compartment syndrome in acute pancreatitis: a systematic review. Pancreas. 2014;43:665\u201374.","journal-title":"Pancreas"},{"key":"3922_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJM199907153410301","volume":"341","author":"RJ Ponec","year":"1999","unstructured":"Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. 1999;341:137\u201341.","journal-title":"N Engl J Med"},{"key":"3922_CR11","first-page":"304","volume":"95","author":"R Amaro","year":"2000","unstructured":"Amaro R, Rogers AI. Neostigmine infusion: new standard of care for acute colonic pseudo-obstruction? Am J Gastroenterol. 2000;95:304\u20135.","journal-title":"Am J Gastroenterol"},{"key":"3922_CR12","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1111\/j.1572-0241.2002.07108.x","volume":"97","author":"CG Loftus","year":"2002","unstructured":"Loftus CG, Harewood GC, Baron TH. Assessment of predictors of response to neostigmine for acute colonic pseudo-obstruction. Am J Gastroenterol. 2002;97:3118\u201322.","journal-title":"Am J Gastroenterol"},{"key":"3922_CR13","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/j.1572-0241.2005.41587.x","volume":"100","author":"MA Korsten","year":"2005","unstructured":"Korsten MA, Rosman AS, Ng A, et al. Infusion of neostigmine-glycopyrrolate for bowel evacuation in persons with spinal cord injury. Am J Gastroenterol. 2005;100:1560\u20135.","journal-title":"Am J Gastroenterol"},{"key":"3922_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1440-1746.2005.03994.x","volume":"21","author":"R Mehta","year":"2006","unstructured":"Mehta R, John A, Nair P, et al. Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo-obstruction: a prospective study. J Gastroenterol Hepatol. 2006;21:459\u201361.","journal-title":"J Gastroenterol Hepatol"},{"key":"3922_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jep.2014.05.040","volume":"155","author":"X Lu","year":"2014","unstructured":"Lu X, Xiao W, Kang X, et al. The effect of Chinese herbal medicine on non-biliogenic severe acute pancreatitis: a systematic review and meta-analysis. J Ethnopharmacol. 2014;155:21\u20139.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"3922_CR16","doi-asserted-by":"publisher","first-page":"CD003631","DOI":"10.1002\/14651858.CD003631.pub2","volume":"2005","author":"W Qiong","year":"2005","unstructured":"Qiong W, Yiping W, Jinlin Y, et al. Chinese medicinal herbs for acute pancreatitis. Cochrane Database Syst Rev. 2005;2005(1):CD003631. https:\/\/doi.org\/10.1002\/14651858.CD003631.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"3922_CR17","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00268-013-2087-5","volume":"37","author":"JK Sun","year":"2013","unstructured":"Sun JK, Li WQ, Ke L, et al. Early enteral nutrition prevents intra-abdominal hypertension and reduces the severity of severe acute pancreatitis compared with delayed enteral nutrition: a prospective pilot study. World J Surg. 2013;37:2053\u201360.","journal-title":"World J Surg"},{"key":"3922_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/0148607112440823","volume":"36","author":"JM Mirtallo","year":"2012","unstructured":"Mirtallo JM, Forbes A, McClave SA, et al. International consensus guidelines for nutrition therapy in pancreatitis. JPEN J Parenter Enteral Nutr. 2012;36:284\u201391.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"3922_CR19","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1001\/jamainternmed.2016.6875","volume":"176","author":"SB Pedersen","year":"2016","unstructured":"Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. 2016;176:1834\u201342.","journal-title":"JAMA Intern Med"},{"key":"3922_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/ajg.2015.261","volume":"110","author":"H Nawaz","year":"2015","unstructured":"Nawaz H, Koutroumpakis E, Easler J, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol. 2015;110:1497\u2013503.","journal-title":"Am J Gastroenterol"},{"key":"3922_CR21","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.clnu.2017.09.028","volume":"37","author":"A Adiamah","year":"2018","unstructured":"Adiamah A, Psaltis E, Crook M, et al. A systematic review of the epidemiology, pathophysiology and current management of hyperlipidaemic pancreatitis. Clin Nutr. 2018;37:1810\u201322.","journal-title":"Clin Nutr"},{"issue":"1","key":"3922_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13054-020-2782-1","volume":"24","author":"IE De Laet","year":"2020","unstructured":"De Laet IE, Malbrain M, De Waele JJ. A clinician\u2019s guide to management of intra-abdominal hypertension and abdominal compartment syndrome in critically Ill patients. Crit Care. 2020;24(1):97.","journal-title":"Crit Care"},{"key":"3922_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/mpa.0b013e318149f5bf","volume":"36","author":"AZ Al-Bahrani","year":"2008","unstructured":"Al-Bahrani AZ, Abid GH, Holt A, et al. Clinical relevance of intra-abdominal hypertension in patients with severe acute pancreatitis. Pancreas. 2008;36:39\u201343.","journal-title":"Pancreas"},{"key":"3922_CR24","doi-asserted-by":"publisher","first-page":"731","DOI":"10.5009\/gnl.2013.7.6.731","volume":"7","author":"V Bhandari","year":"2013","unstructured":"Bhandari V, Jaipuria J, Singh M, et al. Intra-abdominal pressure in the early phase of severe acute pancreatitis: canary in a coal mine? Results from a rigorous validation protocol. Gut Liver. 2013;7:731\u20138.","journal-title":"Gut Liver"},{"key":"3922_CR25","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1053\/j.gastro.2018.01.032","volume":"154","author":"SD Crockett","year":"2018","unstructured":"Crockett SD, Wani S, Gardner TB, et al. American Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018;154:1096\u2013110.","journal-title":"Gastroenterology"},{"key":"3922_CR26","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.clnu.2020.01.004","volume":"39","author":"M Arvanitakis","year":"2020","unstructured":"Arvanitakis M, Ockenga J, Bezmarevic M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clin Nutr. 2020;39:612\u201331.","journal-title":"Clin Nutr"},{"key":"3922_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00134-016-4665-0","volume":"43","author":"A Reintam Blaser","year":"2017","unstructured":"Reintam Blaser A, Starkopf J, Alhazzani W, et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med. 2017;43:380\u201398.","journal-title":"Intensive Care Med"},{"key":"3922_CR28","doi-asserted-by":"publisher","first-page":"108020","DOI":"10.1016\/j.neuropharm.2020.108020","volume":"168","author":"S Vaknine","year":"2020","unstructured":"Vaknine S, Soreq H. Central and peripheral anti-inflammatory effects of acetylcholinesterase inhibitors. Neuropharmacology. 2020;168:108020.","journal-title":"Neuropharmacology"},{"issue":"7","key":"3922_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/cells8070670","volume":"8","author":"DJ Brinkman","year":"2019","unstructured":"Brinkman DJ, Ten Hove AS, Vervoordeldonk MJ, et al. Neuroimmune interactions in the gut and their significance for intestinal immunity. Cells. 2019;8(7):670. https:\/\/doi.org\/10.3390\/cells8070670.","journal-title":"Cells"},{"key":"3922_CR30","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1053\/j.gastro.2006.02.022","volume":"130","author":"DJ van Westerloo","year":"2006","unstructured":"van Westerloo DJ, Giebelen IA, Florquin S, et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology. 2006;130:1822\u201330.","journal-title":"Gastroenterology"},{"key":"3922_CR31","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.hpb.2019.01.015","volume":"21","author":"R Zhang","year":"2019","unstructured":"Zhang R, Deng L, Jin T, et al. Hypertriglyceridaemia-associated acute pancreatitis: diagnosis and impact on severity. HPB (Oxford). 2019;21:1240\u20139.","journal-title":"HPB (Oxford)"},{"key":"3922_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12944-019-1019-2","volume":"18","author":"Y Ding","year":"2019","unstructured":"Ding Y, Zhang M, Wang L, et al. Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis. Lipids Health Dis. 2019;18:93.","journal-title":"Lipids Health Dis"},{"key":"3922_CR33","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1007\/s10620-020-06069-w","volume":"65","author":"X Zheng","year":"2020","unstructured":"Zheng X, Li L, Zhu Y, et al. Superoxide dismutase predicts persistent circulation failure and mortality in the early stage of acute pancreatitis. Dig Dis Sci. 2020;65:3551\u20137.","journal-title":"Dig Dis Sci"},{"key":"3922_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12944-017-0517-3","volume":"16","author":"J Wan","year":"2017","unstructured":"Wan J, He W, Zhu Y, et al. Stratified analysis and clinical significance of elevated serum triglyceride levels in early acute pancreatitis: a retrospective study. Lipids Health Dis. 2017;16:124.","journal-title":"Lipids Health Dis"},{"key":"3922_CR35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.pan.2019.06.006","volume":"19","author":"I Pascual","year":"2019","unstructured":"Pascual I, Sanahuja A, Garcia N, et al. Association of elevated serum triglyceride levels with a more severe course of acute pancreatitis: cohort analysis of 1457 patients. Pancreatology. 2019;19:623\u20139.","journal-title":"Pancreatology"},{"key":"3922_CR36","first-page":"1941","volume":"125","author":"MH Wan","year":"2012","unstructured":"Wan MH, Li J, Huang W, et al. Modified Da-Cheng-Qi decoction reduces intra-abdominal hypertension in severe acute pancreatitis: a pilot study. Chin Med J (Engl). 2012;125:1941\u20134.","journal-title":"Chin Med J (Engl)"},{"key":"3922_CR37","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/jpen.1789","volume":"44","author":"X Chen","year":"2020","unstructured":"Chen X, Yang K, Jing G, et al. Meta-analysis of efficacy of rhubarb combined with early enteral nutrition for the treatment of severe acute pancreatitis. JPEN J Parenter Enteral Nutr. 2020;44:1066\u201378.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"3922_CR38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3760\/cma.j.issn.0366-6999.2009.02.011","volume":"122","author":"EQ Mao","year":"2009","unstructured":"Mao EQ, Tang YQ, Fei J, et al. Fluid therapy for severe acute pancreatitis in acute response stage. Chin Med J (Engl). 2009;122:169\u201373.","journal-title":"Chin Med J (Engl)"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-03922-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-03922-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-03922-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T14:20:19Z","timestamp":1726755619000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-03922-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3922"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-03922-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1047626\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]},"assertion":[{"value":"4 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was registered (ClinicalTrials.gov, No. NCT02543658) and conducted adhering to a protocol that was approved by the Medical Ethics Research Committee of our hospital (2015, No. 011). Written informed consent was obtained from a relative prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Robert Sutton has received research support and\/or funding from Calcimedica, Cypralis, GlaxoSmithKline, MSD\/Merck, and Novartis, has been a consultant for AbbVie, Calcimedica, Cypralis, Eagle Pharmaceuticals, Novartis, and Takeda (all funds to the University of Liverpool), and is collaborating in the IMI2 TransBioLine project with multiple public and private institutions including Janssen, Lilly, MSD\/Merck, Novartis, Pfizer, Roche, and Sanofi-Aventis. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}